Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Cambridge Oesophagogastric Centre, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Gastric Cancer. 2022 Nov;25(6):1094-1104. doi: 10.1007/s10120-022-01318-5. Epub 2022 Jul 13.
Prophylactic total gastrectomy (PTG) remains the only means of preventing gastric cancer for people with genetic mutations predisposing to Hereditary Diffuse Gastric Cancer (HDGC), mainly in the CDH1 gene. The small but growing cohort of people undergoing PTG at a young age are expected to have a life-expectancy close to the general population, however, knowledge of the long-term effects of, and monitoring requirements after, PTG is limited. This study aims to define the standard of care for follow-up after PTG.
Through a combination of literature review and two-round Delphi consensus of major HDGC/PTG units and physicians, and patient advocates, we produced a set of recommendations for follow-up after PTG.
There were 42 first round, and 62 second round, responses from clinicians, allied health professionals and patient advocates. The guidelines include recommendations for timing of assessments and specialties involved in providing follow-up, micronutrient supplementation and monitoring, bone health and the provision of written information.
While the evidence supporting the guidelines is limited, expert consensus provides a framework to best manage people following PTG, and could support the collection of information on the long-term effects of PTG.
预防性全胃切除术 (PTG) 仍然是预防遗传性弥漫性胃癌 (HDGC) 易感基因突变人群胃癌的唯一方法,主要涉及 CDH1 基因。越来越多的年轻人接受预防性全胃切除术,预计他们的预期寿命接近普通人群,但对 PTG 后的长期影响和监测要求知之甚少。本研究旨在确定 PTG 后的随访标准。
通过文献回顾和两轮德尔菲共识(主要的 HDGC/PTG 单位和医生,以及患者代言人),我们制定了一套 PTG 后的随访建议。
共有 42 名临床医生、辅助医疗专业人员和患者代言人在第一轮和 62 名在第二轮中做出了回应。指南包括评估时间和提供随访的专业、微量营养素补充和监测、骨骼健康以及提供书面信息的建议。
虽然支持指南的证据有限,但专家共识为管理接受 PTG 后的人群提供了一个框架,并可以支持收集有关 PTG 长期影响的信息。